Showing results (1501-1510 of 1,826) with videos related to
Sort By:
Pageof 183
Bone Marrow Transplantation|February 27, 2022
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMTEdouard Forcade, Sylvie Chevret, Jürgen Finke, et al.Thorax|November 22, 2019
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)Steve Cunningham, Catriona Graham, Morag MacLean, et al.Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.Frontiers in Immunology|December 31, 2021
HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell TransplantationChrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, et al.Haematologica|December 9, 2017
From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectivesFrancesca Gay, Monika Engelhardt, Evangelos Terpos, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2019
Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell TransplantationRobert Zeiser, Dietrich W Beelen, Wolfgang Bethge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor changeMaximilian Christopeit, Oliver Kuss, Jürgen Finke, et al.Frontiers in Immunology|August 15, 2020
Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMTAndrzej Frankiewicz, Christophe Peczynski, Sebastian Giebel, et al.The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2020
Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelinesRomaana Mir, Sarah M Kelly, Ying Xiao, et al.Pageof 183